Literature DB >> 16809376

Vagal nerve activity contributes to improve the efficiency of pulmonary gas exchange in hypoxic humans.

Shoji Ito1, Hiroshi Sasano, Nobuko Sasano, Junichiro Hayano, Joseph A Fisher, Hirotada Katsuya.   

Abstract

The aim of this study was to test our hypothesis that both phasic cardiac vagal activity and tonic pulmonary vagal activity, estimated as respiratory sinus arrhythmia (RSA) and anatomical dead space volume, respectively, contribute to improve the efficiency of pulmonary gas exchange in humans. We examined the effect of blocking vagal nerve activity with atropine on pulmonary gas exchange. Ten healthy volunteers inhaled hypoxic gas with constant tidal volume and respiratory frequency through a respiratory circuit with a respiratory analyser. Arterial partial pressure of O(2) (P(aO(2))) and arterial oxygen saturation (S(pO(2))) were measured, and alveolar-to-arterial P(O(2)) difference (D(A-aO(2))) was calculated. Anatomical dead space (V(D,an)), alveolar dead space (V(D,alv)) and the ratio of physiological dead space to tidal volume (V(D,phys)/V(T)) were measured. Electrocardiogram was recorded, and the amplitude of R-R interval variability in the high-frequency component (RRIHF) was utilized as an index of RSA magnitude. These parameters of pulmonary function were measured before and after administration of atropine (0.02 mg kg(-1)). Decreased RRIHF (P < 0.01) was accompanied by decreases in P(aO(2)) and S(pO(2)) (P < 0.05 and P < 0.01, respectively) and an increase in D(A-aO(2)) (P < 0.05). Anatomical dead space, V(D,alv) and V(D,phys)/V(T) increased (P < 0.01, P < 0.05 and P < 0.01, respectively) after atropine administration. The blockade of the vagal nerve with atropine resulted in an increase in V(D,an) and V(D,alv) and a deterioration of pulmonary oxygenation, accompanied by attenuation of RSA. Our findings suggest that both phasic cardiac and tonic pulmonary vagal nerve activity contribute to improve the efficiency of pulmonary gas exchange in hypoxic conscious humans.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809376     DOI: 10.1113/expphysiol.2006.034421

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  7 in total

1.  Resting state connectivity of the medial prefrontal cortex covaries with individual differences in high-frequency heart rate variability.

Authors:  J Richard Jennings; Lei K Sheu; Dora C-H Kuan; Stephen B Manuck; Peter J Gianaros
Journal:  Psychophysiology       Date:  2015-11-24       Impact factor: 4.016

2.  Mechanical ventilatory constraints during incremental cycle exercise in human pregnancy: implications for respiratory sensation.

Authors:  Dennis Jensen; Katherine A Webb; Gregory A L Davies; Denis E O'Donnell
Journal:  J Physiol       Date:  2008-08-07       Impact factor: 5.182

3.  Indirect measures of human vagal withdrawal during head-up tilt with and without a respiratory acidosis.

Authors:  S J Brown; T Mundel; M Barnes; J A Brown
Journal:  J Physiol Sci       Date:  2008-11-30       Impact factor: 2.781

4.  Sex Differences in Autonomic Cardiac Control and Oxygen Saturation Response to Short-Term Normobaric Hypoxia and Following Recovery: Effect of Aerobic Fitness.

Authors:  Michal Botek; Jakub Krejčí; Andrew McKune
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-23       Impact factor: 5.555

5.  Use of heart rate variability to predict hospital length of stay for COVID-19 patients: A prospective observational study.

Authors:  Fateme Khodadadi; Sujata Punait; Jacek Kolacz; Farid Zand; Ali Foroutan; Gregory F Lewis
Journal:  Int J Crit Illn Inj Sci       Date:  2021-09-25

6.  Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius.

Authors:  Mak Adam Daulatzai
Journal:  Sleep Disord       Date:  2012-01-16

7.  The physiological effects of slow breathing in the healthy human.

Authors:  Marc A Russo; Danielle M Santarelli; Dean O'Rourke
Journal:  Breathe (Sheff)       Date:  2017-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.